Polio vaccine developer Koprowski dies

This Feb. 1961 file photo show Dr. Hilary Koprowski. Dr. Hilary Koprowski, a pioneering virologist who developed the first successful oral vaccination for polio, died Thursday, April 11, 2013 at his suburban Philadelphia home. He was 96. (AP Photo/File)

Dr. Hilary Koprowski, the Polish-born researcher who developed the first successful oral vaccination for polio, died this week at his Philadelphia home. He was 96.

Although not as well-known as fellow researchers Jonas Salk and Albert Sabin, Koprowski's 1950 clinical trial was the first to show it was possible to vaccinate against polio, the crippling and sometimes fatal disease that's now all but eradicated.

Koprowski's son, Christopher, said Saturday his father liked the scientific recognition his work received without the celebrity of Salk and Sabin.

"He enjoyed not having his scientific work disrupted," said Christopher Koprowski. "Not that he was a modest individual, mind you."

Christopher Koprowski said his father had been sick for several months before dying Thursday in the same home he'd lived in since 1957.

Hilary Koprowski self-administered the live-virus oral vaccine he developed before the 1950 trial—about two years before Salk's injectable version using a dead form of the virus began testing with the backing of the National Foundation for Infantile Paralysis, now the March of Dimes.

Sabin, who Koprowski's son said sometimes collaborated with his father, was the first to get the more effective oral version, which didn't require boosters, licensed for use in the U.S.

Koprowski went on to be the director of The Wistar Institute in Philadelphia from 1957 to 1991. Under his leadership, the independent research institution developed a rubella vaccine that helped eradicate the disease in much of the world, Wistar officials said. It was during that time the institute also developed a more effective rabies vaccine.

A talented musician, Koprowski was a penniless immigrant in Rio de Janeiro making money teaching piano before hooking up with a lab there and eventually moving to the United States, his son said.

"He was a great dad. He was colorful, charismatic," Christopher Koprowski said. "He's still the most brilliant person I've ever met."

4.7 /5 (3 votes)
add to favorites email to friend print save as pdf

Related Stories

Polio's eradication still uncertain

Dec 26, 2007

Efforts to wipe out polio have stalled in recent years and eradication of the crippling disease remains a question mark, U.S. and world experts say.

Is the end of polio truly in sight?

Nov 30, 2011

Declaring the eradication of polio will be far more difficult than it was for smallpox, according to a review published in the Journal of General Virology. Further research into the complex virus - host i ...

Recommended for you

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

Tough-to-abuse formulation of oxycodone approved

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe pain when other ...

EU regulator: Morning-after pill OK for all women

Jul 24, 2014

(AP)—A commonly used morning-after pill is suitable for use by heavier women, the European Medicines Agency said Thursday after a review of the evidence sparked by the French manufacturer's declaration that the drugs didn't ...

User comments

Adjust slider to filter visible comments by rank

Display comments: newest first

Birger
not rated yet Apr 15, 2013
Salk, Sabin and Koprowski have saved millions. They are proof that science trumps new-age "snake oil".
Yet people like this are virtually unknown to the public while the latest pop singer to die from a drug overdose creates headlines...